Theme: Progress in Therapies for heart diseases

Molecular Cardiology 2016

Molecular Cardiology 2016

Conference Series LLC invites all the participants from all over the world to attend  International Cardiology Conferences    i.e. 10th International conference on Molecular & Cellular Cardiology during November 28-30, 2016 in Sao Paulo, Brazil which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions at the  Cardiology meeting.

Molecular Cardiology aims to improve our understanding of the development of cardiovascular disease with a strong emphasis on atherogenesis. Rapid advances in molecular biology in the past decade have changed the practice of clinical cardiology by increasing understanding of molecular mechanisms of cardiovascular disease, and providing new diagnostic and therapeutic tools. It is expected that knowledge in molecular cardiology will grow exponentially in the next few years. Already, molecular and genetic cardiology has increased awareness of the inheritance of defective genes their impact on cardiac disease.

Track 1: Molecular Cardiology

The purpose of the Molecular Cardiology is to study the molecular mechanisms that underlie cardiovascular biology and disease. Molecular Cardiology also focuses on the role of lipid metabolism in the regulation of cell signalling in the heart and vasculature and investigates genetic and biological mechanisms of Heart and Cardiovascular disease. Abnormalities of lipid metabolism, hypertension and angiogenesis have all been shown to play a role in the development and growth of atherosclerotic plaques. Angiotensin II has been shown to induce hypertension, and atherosclerosis in vivo and VEGF (Vascular Endothelial Growth Factor) and angiogenesis in vitro.

Related Conferences

Echo Cardiography Conference July 18-19, 2016 Berlin, Germany; Ischemic Heart Diseases Conference October 21-22, 2016 Chicago, USA; 8th Global Cardiologists Meeting July 18-20, 2016 Berlin, Germany; 9th Arrhythmia and Cardiac Surgery meeting July 14-15 Brisbane, Australia; Annual Conference on Atherosclerosis July 11-12, 2016 Philadelphia, USA; Cardiovascular Medicine Conference August 01-02,2016 Manchester, UK ; 15th World Cardiothoracic Meeting December 05-06, 2016 Philadelphia, USA;  Drug Discovery and Therapy Congress May 11-14, 2016, Boston, USA; American Cardiology Congress 2016; 7th International Conference on Drug Discovery and Therapy, February 15-18, 2016 Dubai, UAE; 13th European Cardiology Congress October 17-19,2016 Rome,  Italy; Arrhythmias & the Heart: A Cardiovascular Update, February 12–16, 2016, Riyadh, Saudi Arabia; 16th Annual International Symposium on Congenital Heart Disease, February 13–16, 2016, St. Petersburg, ACC Annual Meeting 2016; USA; Cardiovascular Conference at Snowbird, February 12-15, 2016, Snowbird, Utah; American Cardiology Congress 2016 ; Korean Cardiology Related Societies Joint Scientific Congress, April 15-16, 2016, Daegu, Korea.

Track 2: Cellular Cardiology

Sympathetic nerve activity has been reported to be increased in both humans and animals with chronic heart failure. One of the mechanisms believed to be responsible for this phenomenon is increased systemic and cerebral angiotensin II signalling. Plasma angiotensin II is increased in humans and animals with chronic heart failure. Blocking angiotensin  II type 1 receptors decreases sympathetic nerve activity and cardiac sympathetic afferent reflex when therapy is administered to the para ventricular nucleus.  Cardiac fibroblasts (CF) are well-established as key regulators of extracellular matrix (ECM) turnover in the context of myocardial remodelling and fibrosis. The increasing availability of detailed, atrial-specific experimental data has stimulated the development of novel computational models of atrial-cellular electrophysiology and Ca2+ -handling. Dysregulation of autophagy in cardiomyocytes is implicated in various heart disease conditions. Beclin 1, a mammalian ortholog (Genes of different species that evolved from common ancestral gene).

Related Conferences

Echo Cardiography Conference July 18-19, 2016 Berlin, Germany; Ischemic Heart Diseases Conference October 21-22, 2016 Chicago, USA; 8th Global Cardiologists Meeting July 18-20, 2016 Berlin, Germany; 9th Arrhythmia and Cardiac Surgery meeting July 14-15 Brisbane, Australia; Annual Conference on Atherosclerosis July 11-12, 2016 Philadelphia, USA; Cardiovascular Medicine Conference August 01-02,2016 Manchester, UK ; 15th World Cardiothoracic Meeting December 05-06, 2016 Philadelphia, USA;  Drug Discovery and Therapy Congress May 11-14, 2016, Boston, USA; American Cardiology Congress 2016; 7th International Conference on Drug Discovery and Therapy, February 15-18, 2016 Dubai, UAE; 13th European Cardiology Congress October 17-19,2016 Rome,  Italy; Arrhythmias & the Heart: A Cardiovascular Update, February 12–16, 2016, Riyadh, Saudi Arabia; 16th Annual International Symposium on Congenital Heart Disease, February 13–16, 2016, St. Petersburg, ACC Annual Meeting 2016; USA; Cardiovascular Conference at Snowbird, February 12-15, 2016, Snowbird, Utah; American Cardiology Congress 2016 ; Korean Cardiology Related Societies Joint Scientific Congress, April 15-16, 2016, Daegu, Korea.

Track 3: Nuclear Cardiology

A non-invasive method for studying cardiovascular disease by use of nuclear imaging techniques. These examinations are usually done while the individual is exercising. Coronary artery disease can be investigated as can damage to the myocardium following coronary infarction. The size and function of the ventricles can be evaluated using these techniques. It makes possible primarily functional assessment of the heart with quantification of perfusion and systolic function. Development of new types of scanners for nuclear cardiology brings more possibilities in research and clinical practice. This paper describes a brief review of some applications of cadmium–zinc–telluride (CZT) scanners in comparison with conventional cameras.

Related Conferences

Echo Cardiography Conference July 18-19, 2016 Berlin, Germany; Ischemic Heart Diseases Conference October 21-22, 2016 Chicago, USA; 8th Global Cardiologists Meeting July 18-20, 2016 Berlin, Germany; 9th Arrhythmia and Cardiac Surgery meeting July 14-15 Brisbane, Australia; Annual Conference on Atherosclerosis July 11-12, 2016 Philadelphia, USA; Cardiovascular Medicine Conference August 01-02,2016 Manchester, UK ; 15th World Cardiothoracic Meeting December 05-06, 2016 Philadelphia, USA;  Drug Discovery and Therapy Congress May 11-14, 2016, Boston, USA; American Cardiology Congress 2016; 7th International Conference on Drug Discovery and Therapy, February 15-18, 2016 Dubai, UAE; 13th European Cardiology Congress October 17-19,2016 Rome,  Italy; Arrhythmias & the Heart: A Cardiovascular Update, February 12–16, 2016, Riyadh, Saudi Arabia; 16th Annual International Symposium on Congenital Heart Disease, February 13–16, 2016, St. Petersburg, ACC Annual Meeting 2016; USA; Cardiovascular Conference at Snowbird, February 12-15, 2016, Snowbird, Utah; American Cardiology Congress 2016 ; Korean Cardiology Related Societies Joint Scientific Congress, April 15-16, 2016, Daegu, Korea.

Track 4: Cardio-Oncology

Cardio-oncology, or onco-cardiology, is the discipline that focuses on the intersection of cardiovascular disease and cancer. With the prognosis for many cancers improving, we are seeing an appropriate sharpening of focus on the cardiovascular risks of patients who have survived cancer or are being treated for cancer, as well as a growing recognition of the impact this competing morbidity has on both short- and long-term health outcomes.

Related Conferences

Echo Cardiography Conference July 18-19, 2016 Berlin, Germany; Ischemic Heart Diseases Conference October 21-22, 2016 Chicago, USA; 8th Global Cardiologists Meeting July 18-20, 2016 Berlin, Germany; 9th Arrhythmia and Cardiac Surgery meeting July 14-15 Brisbane, Australia; Annual Conference on Atherosclerosis July 11-12, 2016 Philadelphia, USA; Cardiovascular Medicine Conference August 01-02,2016 Manchester, UK ; 15th World Cardiothoracic Meeting December 05-06, 2016 Philadelphia, USA;  Drug Discovery and Therapy Congress May 11-14, 2016, Boston, USA; American Cardiology Congress 2016; 7th International Conference on Drug Discovery and Therapy, February 15-18, 2016 Dubai, UAE; 13th European Cardiology Congress October 17-19,2016 Rome,  Italy; Arrhythmias & the Heart: A Cardiovascular Update, February 12–16, 2016, Riyadh, Saudi Arabia; 16th Annual International Symposium on Congenital Heart Disease, February 13–16, 2016, St. Petersburg, ACC Annual Meeting 2016; USA; Cardiovascular Conference at Snowbird, February 12-15, 2016, Snowbird, Utah; American Cardiology Congress 2016 ; Korean Cardiology Related Societies Joint Scientific Congress, April 15-16, 2016, Daegu, Korea.

Track 5: Arrhythmias and Cardiac Cirrhosis

Arrhythmia/cardiac dysrhythmia means irregular heart beats or heart rhythm where muscles of heart contract in a coordinated fashion to insure that blood is been efficiently pumped into the arteries and the extra heart beat are due to premature atrial contraction and premature ventricular contraction. Cardiac cirrhosis (congestive hepatopathy) includes a spectrum of hepatic derangements that occur in the setting of right-sided heart failure. Clinically, the signs and symptoms of congestive heart failure (CHF) dominate the disorder. Unlike cirrhosis caused by chronic alcohol use or viral hepatitis, the effect of cardiac cirrhosis on overall prognosis has not been clearly established. As a result, treatment is aimed at managing the underlying heart failure. A separate theory proposes that cardiac cirrhosis is not simply a response to chronically increased pressure and sinusoidal stasis. Because intrahepatic vascular lesions are confined to areas of the liver with higher fibrotic burden, cardiac cirrhosis may require a higher grade of vascular obstruction, such as intrahepatic thrombosis, for its development.

Related Conferences

Echo Cardiography Conference July 18-19, 2016 Berlin, Germany; Ischemic Heart Diseases Conference October 21-22, 2016 Chicago, USA; 8th Global Cardiologists Meeting July 18-20, 2016 Berlin, Germany; 9th Arrhythmia and Cardiac Surgery meeting July 14-15 Brisbane, Australia; Annual Conference on Atherosclerosis July 11-12, 2016 Philadelphia, USA; Cardiovascular Medicine Conference August 01-02,2016 Manchester, UK ; 15th World Cardiothoracic Meeting December 05-06, 2016 Philadelphia, USA;  Drug Discovery and Therapy Congress May 11-14, 2016, Boston, USA; American Cardiology Congress 2016; 7th International Conference on Drug Discovery and Therapy, February 15-18, 2016 Dubai, UAE; 13th European Cardiology Congress October 17-19,2016 Rome,  Italy; Arrhythmias & the Heart: A Cardiovascular Update, February 12–16, 2016, Riyadh, Saudi Arabia; 16th Annual International Symposium on Congenital Heart Disease, February 13–16, 2016, St. Petersburg, ACC Annual Meeting 2016; USA; Cardiovascular Conference at Snowbird, February 12-15, 2016, Snowbird, Utah; American Cardiology Congress 2016 ; Korean Cardiology Related Societies Joint Scientific Congress, April 15-16, 2016, Daegu, Korea.

Track 6: Interventional & Translational Cardiology

Interventional cardiology is a branch of cardiology that deals specifically with the catheter based treatment of structural heart diseases. Interventional cardiology refers to diagnostics and non-surgical treatments of the heart.
Translational medicine is a rapidly growing discipline in biomedical research and aims to expedite the discovery of new diagnostic tools and treatments by using a multi-disciplinary, highly collaborative, "bench-to-bedside" approach. Within public health, translational medicine is focused on ensuring that proven strategies for disease treatment and prevention are actually implemented within the community.

Related Conferences

Echo Cardiography Conference July 18-19, 2016 Berlin, Germany; Ischemic Heart Diseases Conference October 21-22, 2016 Chicago, USA; 8th Global Cardiologists Meeting July 18-20, 2016 Berlin, Germany; 9th Arrhythmia and Cardiac Surgery meeting July 14-15 Brisbane, Australia; Annual Conference on Atherosclerosis July 11-12, 2016 Philadelphia, USA; Cardiovascular Medicine Conference August 01-02,2016 Manchester, UK ; 15th World Cardiothoracic Meeting December 05-06, 2016 Philadelphia, USA;  Drug Discovery and Therapy Congress May 11-14, 2016, Boston, USA; American Cardiology Congress 2016; 7th International Conference on Drug Discovery and Therapy, February 15-18, 2016 Dubai, UAE; 13th European Cardiology Congress October 17-19,2016 Rome,  Italy; Arrhythmias & the Heart: A Cardiovascular Update, February 12–16, 2016, Riyadh, Saudi Arabia; 16th Annual International Symposium on Congenital Heart Disease, February 13–16, 2016, St. Petersburg, ACC Annual Meeting 2016; USA; Cardiovascular Conference at Snowbird, February 12-15, 2016, Snowbird, Utah; American Cardiology Congress 2016 ; Korean Cardiology Related Societies Joint Scientific Congress, April 15-16, 2016, Daegu, Korea.

Track 7: Cardiogenic Pulmonary Edema

Cardiogenic pulmonary edema (CPE) is defined as pulmonary Edema due to increased capillary hydrostatic pressure secondary to elevated pulmonary venous pressure. CPE reflects the accumulation of fluid with alow-protein content in the lung interstitium and alveoli as a result of cardiac dysfunction. CPE leads to progressive deterioration of alveolar gas exchange and respiratory failure. Without prompt recognition and treatment, a patient's condition can deteriorate rapidly. The major complications associated with CPE are respiratory fatigue and failure.

Related Conferences

Echo Cardiography Conference July 18-19, 2016 Berlin, Germany; Ischemic Heart Diseases Conference October 21-22, 2016 Chicago, USA; 8th Global Cardiologists Meeting July 18-20, 2016 Berlin, Germany; 9th Arrhythmia and Cardiac Surgery meeting July 14-15 Brisbane, Australia; Annual Conference on Atherosclerosis July 11-12, 2016 Philadelphia, USA; Cardiovascular Medicine Conference August 01-02,2016 Manchester, UK ; 15th World Cardiothoracic Meeting December 05-06, 2016 Philadelphia, USA;  Drug Discovery and Therapy Congress May 11-14, 2016, Boston, USA; American Cardiology Congress 2016; 7th International Conference on Drug Discovery and Therapy, February 15-18, 2016 Dubai, UAE; 13th European Cardiology Congress October 17-19,2016 Rome,  Italy; Arrhythmias & the Heart: A Cardiovascular Update, February 12–16, 2016, Riyadh, Saudi Arabia; 16th Annual International Symposium on Congenital Heart Disease, February 13–16, 2016, St. Petersburg, ACC Annual Meeting 2016; USA; Cardiovascular Conference at Snowbird, February 12-15, 2016, Snowbird, Utah; American Cardiology Congress 2016 ; Korean Cardiology Related Societies Joint Scientific Congress, April 15-16, 2016, Daegu, Korea.

Track 8: Cardiac vascular Aging

Cardiac aging is a heterogeneous process caused by a combination of stochastic events which manifests as loss of structure and function in the heart, however several recent studies draw attention to aging being primarily a stem cell problem. Autophagy, a cellular housekeeping process, is essential to maintain tissue homeostasis, particularly in long-lived cells such as cardiomyocytes. Autophagic activity declines with age and may explain many features of age-related cardiac dysfunction. Impaired autophagic clearance of protein aggregates or deteriorating mitochondria will have multiple consequences including increased arrhythmia risk, decreased contractile function, reduced tolerance to ischemic stress, and increased inflammation; thus autophagy represents a potentially important therapeutic target to mitigate the cardiac consequences of aging. Aging results in progressive deteriorations in the structure and function of the heart and is a dominant risk factor for cardiovascular diseases, the leading cause of death in Western populations

Related Conferences

Echo Cardiography Conference July 18-19, 2016 Berlin, Germany; Ischemic Heart Diseases Conference October 21-22, 2016 Chicago, USA; 8th Global Cardiologists Meeting July 18-20, 2016 Berlin, Germany; 9th Arrhythmia and Cardiac Surgery meeting July 14-15 Brisbane, Australia; Annual Conference on Atherosclerosis July 11-12, 2016 Philadelphia, USA; Cardiovascular Medicine Conference August 01-02,2016 Manchester, UK ; 15th World Cardiothoracic Meeting December 05-06, 2016 Philadelphia, USA;  Drug Discovery and Therapy Congress May 11-14, 2016, Boston, USA; American Cardiology Congress 2016; 7th International Conference on Drug Discovery and Therapy, February 15-18, 2016 Dubai, UAE; 13th European Cardiology Congress October 17-19,2016 Rome,  Italy; Arrhythmias & the Heart: A Cardiovascular Update, February 12–16, 2016, Riyadh, Saudi Arabia; 16th Annual International Symposium on Congenital Heart Disease, February 13–16, 2016, St. Petersburg, ACC Annual Meeting 2016; USA; Cardiovascular Conference at Snowbird, February 12-15, 2016, Snowbird, Utah; American Cardiology Congress 2016 ; Korean Cardiology Related Societies Joint Scientific Congress, April 15-16, 2016, Daegu, Korea.

Track 9: Hypertension and Cardiac Progenitors

Hypertension (HTN or HT), also known as high blood pressure, is a long term medical condition in which the blood pressure in the arteries is persistently elevated.[1] High blood pressure usually does not cause symptoms.[2] Long term high blood pressure; however, is a major risk factor for coronary artery disease, stroke, heart failure, peripheral vascular disease, vision loss, and chronic kidney disease. Cardiac progenitor cells (CPCs) are committed to the cardiac lineage but retain their proliferative capacity before becoming quiescent mature cardiomyocytes (CMs). In medical therapy and research, the use of human pluripotent stem cell-derived CPCs would have several advantages compared with mature CMs, as the progenitors show better engraftment into existing heart tissues, and provide unique potential for cardiovascular developmental as well as for pharmacological studies. Cardiac progenitor cells (CPCs) represent the earliest stages of mesoderm commitment to the cardiac lineages and directed differentiation of CPCs from pluripotent stem cells has been demonstrated in a number of recent studies. Furthermore, these cells have been shown to be capable of generating other terminal cardiac cell types such as cardiomyocytes, endothelial cells, and vascular smooth muscle cells.  However, utilization of CPCs for such endeavors requires a robust, scalable, and consistent differentiation methodology.

Related Conferences

Echo Cardiography Conference July 18-19, 2016 Berlin, Germany; Ischemic Heart Diseases Conference October 21-22, 2016 Chicago, USA; 8th Global Cardiologists Meeting July 18-20, 2016 Berlin, Germany; 9th Arrhythmia and Cardiac Surgery meeting July 14-15 Brisbane, Australia; Annual Conference on Atherosclerosis July 11-12, 2016 Philadelphia, USA; Cardiovascular Medicine Conference August 01-02,2016 Manchester, UK ; 15th World Cardiothoracic Meeting December 05-06, 2016 Philadelphia, USA;  Drug Discovery and Therapy Congress May 11-14, 2016, Boston, USA; American Cardiology Congress 2016; 7th International Conference on Drug Discovery and Therapy, February 15-18, 2016 Dubai, UAE; 13th European Cardiology Congress October 17-19,2016 Rome,  Italy; Arrhythmias & the Heart: A Cardiovascular Update, February 12–16, 2016, Riyadh, Saudi Arabia; 16th Annual International Symposium on Congenital Heart Disease, February 13–16, 2016, St. Petersburg, ACC Annual Meeting 2016; USA; Cardiovascular Conference at Snowbird, February 12-15, 2016, Snowbird, Utah; American Cardiology Congress 2016 ; Korean Cardiology Related Societies Joint Scientific Congress, April 15-16, 2016, Daegu, Korea.

Track 10: Heart Failure And Atrial Fibrillation

Heart failure, sometimes known as congestive heart failure, occurs when your heart muscle doesn't pump blood as well as it should. Common causes of heart failure include coronary artery disease including a previous myocardial infarction (heart attack), high blood pressure, atrial fibrillation, valvular heart disease, excess alcohol use, infection, and cardiomyopathy of an unknown cause. Atrial fibrillation is the most common serious abnormal heart rhythm. Rapid and irregular heart rates may be perceived as palpitations or exercise intolerance and occasionally may produce anginal chest pain.
 

Related Conferences

Echo Cardiography Conference July 18-19, 2016 Berlin, Germany; Ischemic Heart Diseases Conference October 21-22, 2016 Chicago, USA; 8th Global Cardiologists Meeting July 18-20, 2016 Berlin, Germany; 9th Arrhythmia and Cardiac Surgery meeting July 14-15 Brisbane, Australia; Annual Conference on Atherosclerosis July 11-12, 2016 Philadelphia, USA; Cardiovascular Medicine Conference August 01-02,2016 Manchester, UK ; 15th World Cardiothoracic Meeting December 05-06, 2016 Philadelphia, USA;  Drug Discovery and Therapy Congress May 11-14, 2016, Boston, USA; American Cardiology Congress 2016; 7th International Conference on Drug Discovery and Therapy, February 15-18, 2016 Dubai, UAE; 13th European Cardiology Congress October 17-19,2016 Rome,  Italy; Arrhythmias & the Heart: A Cardiovascular Update, February 12–16, 2016, Riyadh, Saudi Arabia; 16th Annual International Symposium on Congenital Heart Disease, February 13–16, 2016, St. Petersburg, ACC Annual Meeting 2016; USA; Cardiovascular Conference at Snowbird, February 12-15, 2016, Snowbird, Utah; American Cardiology Congress 2016 ; Korean Cardiology Related Societies Joint Scientific Congress, April 15-16, 2016, Daegu, Korea.

Track 11: Cardiac Hypertrophy

Cardiac hypertrophy is defined as an increase in the size of the heart caused by an increase in the size of the cardiomyocytes therein, which is achieved by an increase in the number of sarcomeres, a basic unit of a muscle's cross-striated myofibril. Cardiac hypertrophy is caused by hemodynamic overload, which includes pressure overload (PO) caused by aortic stenosis and high blood pressure, and volume overload (VO) caused by valvular insufficiency, chronic myocardial infarction, arteriovenous shunt, and pregnancy. PO causes “concentric” hypertrophy, characterized by increased ventricular wall thickness and little chamber dilation, where parallel addition of sarcomeres increases the size of cardiomyocytes in both minor and major axes. In contrast, VO results in “eccentric” hypertrophy, characterized by increased ventricular volume with little increase in the wall thickness, where serial addition of sarcomeres increases the size of cardiomyocytes primarily by elongation.

Related Conferences

Echo Cardiography Conference July 18-19, 2016 Berlin, Germany; Ischemic Heart Diseases Conference October 21-22, 2016 Chicago, USA; 8th Global Cardiologists Meeting July 18-20, 2016 Berlin, Germany; 9th Arrhythmia and Cardiac Surgery meeting July 14-15 Brisbane, Australia; Annual Conference on Atherosclerosis July 11-12, 2016 Philadelphia, USA; Cardiovascular Medicine Conference August 01-02,2016 Manchester, UK ; 15th World Cardiothoracic Meeting December 05-06, 2016 Philadelphia, USA;  Drug Discovery and Therapy Congress May 11-14, 2016, Boston, USA; American Cardiology Congress 2016; 7th International Conference on Drug Discovery and Therapy, February 15-18, 2016 Dubai, UAE; 13th European Cardiology Congress October 17-19,2016 Rome,  Italy; Arrhythmias & the Heart: A Cardiovascular Update, February 12–16, 2016, Riyadh, Saudi Arabia; 16th Annual International Symposium on Congenital Heart Disease, February 13–16, 2016, St. Petersburg, ACC Annual Meeting 2016; USA; Cardiovascular Conference at Snowbird, February 12-15, 2016, Snowbird, Utah; American Cardiology Congress 2016 ; Korean Cardiology Related Societies Joint Scientific Congress, April 15-16, 2016, Daegu, Korea.

Track 12: Cardiac Imaging and Instrumentation

Cardiac imaging techniques include coronary catheterization, echocardiogram, Intravascular ultrasound, Cardiac PET scan, Cardiac CT scan and Cardiac MRI.

Related Conferences

Echo Cardiography Conference July 18-19, 2016 Berlin, Germany; Ischemic Heart Diseases Conference October 21-22, 2016 Chicago, USA; 8th Global Cardiologists Meeting July 18-20, 2016 Berlin, Germany; 9th Arrhythmia and Cardiac Surgery meeting July 14-15 Brisbane, Australia; Annual Conference on Atherosclerosis July 11-12, 2016 Philadelphia, USA; Cardiovascular Medicine Conference August 01-02,2016 Manchester, UK ; 15th World Cardiothoracic Meeting December 05-06, 2016 Philadelphia, USA;  Drug Discovery and Therapy Congress May 11-14, 2016, Boston, USA; American Cardiology Congress 2016; 7th International Conference on Drug Discovery and Therapy, February 15-18, 2016 Dubai, UAE; 13th European Cardiology Congress October 17-19,2016 Rome,  Italy; Arrhythmias & the Heart: A Cardiovascular Update, February 12–16, 2016, Riyadh, Saudi Arabia; 16th Annual International Symposium on Congenital Heart Disease, February 13–16, 2016, St. Petersburg, ACC Annual Meeting 2016; USA; Cardiovascular Conference at Snowbird, February 12-15, 2016, Snowbird, Utah; American Cardiology Congress 2016 ; Korean Cardiology Related Societies Joint Scientific Congress, April 15-16, 2016, Daegu, Korea.

Track13: Cardiologists training and Education

Cardiologists are doctors who specialize in diagnosing and treating diseases or conditions of the heart and blood vessels—the cardiovascular system. You might also visit a cardiologist so you can learn about your risk factors for heart disease and find out what measures you can take for better heart health. When you are dealing with a complex health condition like heart disease, it is important that you find the right match between you and your specialist. 

Related Conferences

Echo Cardiography Conference July 18-19, 2016 Berlin, Germany; Ischemic Heart Diseases Conference October 21-22, 2016 Chicago, USA; 8th Global Cardiologists Meeting July 18-20, 2016 Berlin, Germany; 9th Arrhythmia and Cardiac Surgery meeting July 14-15 Brisbane, Australia; Annual Conference on Atherosclerosis July 11-12, 2016 Philadelphia, USA; Cardiovascular Medicine Conference August 01-02,2016 Manchester, UK ; 15th World Cardiothoracic Meeting December 05-06, 2016 Philadelphia, USA;  Drug Discovery and Therapy Congress May 11-14, 2016, Boston, USA; American Cardiology Congress 2016; 7th International Conference on Drug Discovery and Therapy, February 15-18, 2016 Dubai, UAE; 13th European Cardiology Congress October 17-19,2016 Rome,  Italy; Arrhythmias & the Heart: A Cardiovascular Update, February 12–16, 2016, Riyadh, Saudi Arabia; 16th Annual International Symposium on Congenital Heart Disease, February 13–16, 2016, St. Petersburg, ACC Annual Meeting 2016; USA; Cardiovascular Conference at Snowbird, February 12-15, 2016, Snowbird, Utah; American Cardiology Congress 2016 ; Korean Cardiology Related Societies Joint Scientific Congress, April 15-16, 2016, Daegu, Korea.

Track 14: Pediatric Cardiology and Cardiologists

Pediatric Cardiology is responsible for the diagnosis of congenital heart defects, performing diagnostic procedures such as echocardiograms, cardiac catheterizations, and for the on-going   management of the sequel of heart disease in infants, children and adolescents. The division is actively involved in research aimed at preventing both congenital and acquired heart disease in children. Finally, the division is committed to educating the next generation of physicians, and offers advanced training in pediatric cardiology.

Related Conferences

Echo Cardiography Conference July 18-19, 2016 Berlin, Germany; Ischemic Heart Diseases Conference October 21-22, 2016 Chicago, USA; 8th Global Cardiologists Meeting July 18-20, 2016 Berlin, Germany; 9th Arrhythmia and Cardiac Surgery meeting July 14-15 Brisbane, Australia; Annual Conference on Atherosclerosis July 11-12, 2016 Philadelphia, USA; Cardiovascular Medicine Conference August 01-02,2016 Manchester, UK ; 15th World Cardiothoracic Meeting December 05-06, 2016 Philadelphia, USA;  Drug Discovery and Therapy Congress May 11-14, 2016, Boston, USA; American Cardiology Congress 2016; 7th International Conference on Drug Discovery and Therapy, February 15-18, 2016 Dubai, UAE; 13th European Cardiology Congress October 17-19,2016 Rome,  Italy; Arrhythmias & the Heart: A Cardiovascular Update, February 12–16, 2016, Riyadh, Saudi Arabia; 16th Annual International Symposium on Congenital Heart Disease, February 13–16, 2016, St. Petersburg, ACC Annual Meeting 2016; USA; Cardiovascular Conference at Snowbird, February 12-15, 2016, Snowbird, Utah; American Cardiology Congress 2016 ; Korean Cardiology Related Societies Joint Scientific Congress, April 15-16, 2016, Daegu, Korea.

Track 15: Advances in Cardiology education

Cardiology is a branch of medicine dealing with disorders of the heart is it human or animal. The field includes medical diagnosis and treatment of congenital heart defects, coronary artery disease, heart failure, valvular heart disease and electrophysiology. Physicians who specialize in this field of medicine are called cardiologists.

Related Conferences

Echo Cardiography Conference July 18-19, 2016 Berlin, Germany; Ischemic Heart Diseases Conference October 21-22, 2016 Chicago, USA; 8th Global Cardiologists Meeting July 18-20, 2016 Berlin, Germany; 9th Arrhythmia and Cardiac Surgery meeting July 14-15 Brisbane, Australia; Annual Conference on Atherosclerosis July 11-12, 2016 Philadelphia, USA; Cardiovascular Medicine Conference August 01-02,2016 Manchester, UK ; 15th World Cardiothoracic Meeting December 05-06, 2016 Philadelphia, USA;  Drug Discovery and Therapy Congress May 11-14, 2016, Boston, USA; American Cardiology Congress 2016; 7th International Conference on Drug Discovery and Therapy, February 15-18, 2016 Dubai, UAE; 13th European Cardiology Congress October 17-19,2016 Rome,  Italy; Arrhythmias & the Heart: A Cardiovascular Update, February 12–16, 2016, Riyadh, Saudi Arabia; 16th Annual International Symposium on Congenital Heart Disease, February 13–16, 2016, St. Petersburg, ACC Annual Meeting 2016; USA; Cardiovascular Conference at Snowbird, February 12-15, 2016, Snowbird, Utah; American Cardiology Congress 2016 ; Korean Cardiology Related Societies Joint Scientific Congress, April 15-16, 2016, Daegu, Korea.

Track 16: Clinical trials in Cardiology

Clinical trials are experiments done in clinical research. Such prospective biomedical or behavioural research studies on human participants are designed to answer specific questions about biomedical or behavioural interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that warrant further study and comparison. Clinical trials generate data on safety and efficacy.

Related Conferences

Echo Cardiography Conference July 18-19, 2016 Berlin, Germany; Ischemic Heart Diseases Conference October 21-22, 2016 Chicago, USA; 8th Global Cardiologists Meeting July 18-20, 2016 Berlin, Germany; 9th Arrhythmia and Cardiac Surgery meeting July 14-15 Brisbane, Australia; Annual Conference on Atherosclerosis July 11-12, 2016 Philadelphia, USA; Cardiovascular Medicine Conference August 01-02,2016 Manchester, UK ; 15th World Cardiothoracic Meeting December 05-06, 2016 Philadelphia, USA;  Drug Discovery and Therapy Congress May 11-14, 2016, Boston, USA; American Cardiology Congress 2016; 7th International Conference on Drug Discovery and Therapy, February 15-18, 2016 Dubai, UAE; 13th European Cardiology Congress October 17-19,2016 Rome,  Italy; Arrhythmias & the Heart: A Cardiovascular Update, February 12–16, 2016, Riyadh, Saudi Arabia; 16th Annual International Symposium on Congenital Heart Disease, February 13–16, 2016, St. Petersburg, ACC Annual Meeting 2016; USA; Cardiovascular Conference at Snowbird, February 12-15, 2016, Snowbird, Utah; American Cardiology Congress 2016 ; Korean Cardiology Related Societies Joint Scientific Congress, April 15-16, 2016, Daegu, Korea.

Track 17: Regulation of Cardiac Function

Various intrinsic, neural, and hormonal factors act to influence the rhythm control and impulse conduction within the heart. The rhythmic control of the cardiac cycle and its accompanying heart beat relies on the regulation of impulses generated and conducted within the heart. Regulation of the cardiac cycle is also achieved via the autonomic nervous system. The sympathetic and parasympathetic divisions of the autonomic system regulate heart rhythm by affecting the same intrinsic impulse conducting mechanisms that lie within the heart in opposing ways. The cardiovascular system is subject to precise reflux regulation so that an appropriate supply of oxygenated blood can be reliably provided to different body tissues under a wide range of circumstances. The sensory monitoring for this critical homeostatic process entails primarily mechanical (Barosensory) information about pressure in the arterial system and, secondarily, chemical (chemosensory) information about the level of oxygen and carbon dioxide in the blood. The parasympathetic and sympathetic activity relevant to cardiovascular control is determined by the information supplied by these sensors.

Related Conferences

Echo Cardiography Conference July 18-19, 2016 Berlin, Germany; Ischemic Heart Diseases Conference October 21-22, 2016 Chicago, USA; 8th Global Cardiologists Meeting July 18-20, 2016 Berlin, Germany; 9th Arrhythmia and Cardiac Surgery meeting July 14-15 Brisbane, Australia; Annual Conference on Atherosclerosis July 11-12, 2016 Philadelphia, USA; Cardiovascular Medicine Conference August 01-02,2016 Manchester, UK ; 15th World Cardiothoracic Meeting December 05-06, 2016 Philadelphia, USA;  Drug Discovery and Therapy Congress May 11-14, 2016, Boston, USA; American Cardiology Congress 2016; 7th International Conference on Drug Discovery and Therapy, February 15-18, 2016 Dubai, UAE; 13th European Cardiology Congress October 17-19,2016 Rome,  Italy; Arrhythmias & the Heart: A Cardiovascular Update, February 12–16, 2016, Riyadh, Saudi Arabia; 16th Annual International Symposium on Congenital Heart Disease, February 13–16, 2016, St. Petersburg, ACC Annual Meeting 2016; USA; Cardiovascular Conference at Snowbird, February 12-15, 2016, Snowbird, Utah; American Cardiology Congress 2016 ; Korean Cardiology Related Societies Joint Scientific Congress, April 15-16, 2016, Daegu, Korea.

Track 18: Recent Innovations in Molecular Cardiology

Molecular cardiology is a new and fast-growing area of cardiovascular medicine that aims to apply molecular biology techniques for the mechanistic investigation, diagnosis, prevention and treatment of cardiovascular disease. As an emerging discipline, it has changed conceptual thinking of cardiovascular development, disease etiology and pathophysiology. Although molecular cardiology is still at a very early stage, it has opened a promising avenue for understanding and controlling cardiovascular disease. With the rapid development and application of molecular biology techniques, scientists and clinicians are closer to curing heart diseases that were thought to be incurable 20 years ago. There clearly is a need for a more thorough understanding of the molecular mechanisms of cardiovascular diseases to promote the advancement of stem cell therapy and gene therapy for heart diseases.

Related Conferences

Echo Cardiography Conference July 18-19, 2016 Berlin, Germany; Ischemic Heart Diseases Conference October 21-22, 2016 Chicago, USA; 8th Global Cardiologists Meeting July 18-20, 2016 Berlin, Germany; 9th Arrhythmia and Cardiac Surgery meeting July 14-15 Brisbane, Australia; Annual Conference on Atherosclerosis July 11-12, 2016 Philadelphia, USA; Cardiovascular Medicine Conference August 01-02,2016 Manchester, UK ; 15th World Cardiothoracic Meeting December 05-06, 2016 Philadelphia, USA;  Drug Discovery and Therapy Congress May 11-14, 2016, Boston, USA; American Cardiology Congress 2016; 7th International Conference on Drug Discovery and Therapy, February 15-18, 2016 Dubai, UAE; 13th European Cardiology Congress October 17-19,2016 Rome,  Italy; Arrhythmias & the Heart: A Cardiovascular Update, February 12–16, 2016, Riyadh, Saudi Arabia; 16th Annual International Symposium on Congenital Heart Disease, February 13–16, 2016, St. Petersburg, ACC Annual Meeting 2016; USA; Cardiovascular Conference at Snowbird, February 12-15, 2016, Snowbird, Utah; American Cardiology Congress 2016 ; Korean Cardiology Related Societies Joint Scientific Congress, April 15-16, 2016, Daegu, Korea.

Track 19: Case Reports on Cardiac

Cardiac involvement is the most important cause of death in patients with sarcoidosis, yielding a 5-year mortality risk up to 66% despite appropriate immunosuppressive treatment. Early diagnosis and prompt initiation of corticosteroid therapy in this population has proven to improve left ventricular (LV) function though, at the same time reducing risk of malignant arrhythmia. Recently, two-dimensional speckle-tracking echocardiography has been introduced as a new and highly sensitive echocardiographic technique to assess regional and global biventricular performance, detecting myocardial tissue diseases even in the pre-clinical stage. We report a histology proven case of cardiac sarcoidosis in which strain curves of each LV segment were matched to macroscopic findings of the explanted heart, with the aim to test accuracy of deformation imaging in identifying specific areas involved by myocardial infiltration/inflammation.

Related Conferences

Echo Cardiography Conference July 18-19, 2016 Berlin, Germany; Ischemic Heart Diseases Conference October 21-22, 2016 Chicago, USA; 8th Global Cardiologists Meeting July 18-20, 2016 Berlin, Germany; 9th Arrhythmia and Cardiac Surgery meeting July 14-15 Brisbane, Australia; Annual Conference on Atherosclerosis July 11-12, 2016 Philadelphia, USA; Cardiovascular Medicine Conference August 01-02,2016 Manchester, UK ; 15th World Cardiothoracic Meeting December 05-06, 2016 Philadelphia, USA;  Drug Discovery and Therapy Congress May 11-14, 2016, Boston, USA; American Cardiology Congress 2016; 7th International Conference on Drug Discovery and Therapy, February 15-18, 2016 Dubai, UAE; 13th European Cardiology Congress October 17-19,2016 Rome,  Italy; Arrhythmias & the Heart: A Cardiovascular Update, February 12–16, 2016, Riyadh, Saudi Arabia; 16th Annual International Symposium on Congenital Heart Disease, February 13–16, 2016, St. Petersburg, ACC Annual Meeting 2016; USA; Cardiovascular Conference at Snowbird, February 12-15, 2016, Snowbird, Utah; American Cardiology Congress 2016 ; Korean Cardiology Related Societies Joint Scientific Congress, April 15-16, 2016, Daegu, Korea.

Track 20: Entrepreneurs Investment Meet

Entrepreneurs  is an individual who, rather than working as an employee, runs a small business and assumes all the risk and reward of a given business venture, idea, or good or service offered for sale. The Cardio vascular Devices entrepreneur is commonly seen as a business leader and innovator of new ideas and business processes working on Medical devices. Entrepreneurs play a key role in any economy. These are the people who have the skills and initiative necessary to take good new ideas to cardiothoracic devices market and make the right decisions to make the idea profitable. Cardiac Devices Entrepreneurs Investment Meeting is a gathering of Cardiac Devices. Entrepreneurs  and Investors that has been convened for the purpose of achieving a common goal through verbal interaction, such as sharing information or reaching agreement.

Related Conferences

Echo Cardiography Conference July 18-19, 2016 Berlin, Germany; Ischemic Heart Diseases Conference October 21-22, 2016 Chicago, USA; 8th Global Cardiologists Meeting July 18-20, 2016 Berlin, Germany; 9th Arrhythmia and Cardiac Surgery meeting July 14-15 Brisbane, Australia; Annual Conference on Atherosclerosis July 11-12, 2016 Philadelphia, USA; Cardiovascular Medicine Conference August 01-02,2016 Manchester, UK ; 15th World Cardiothoracic Meeting December 05-06, 2016 Philadelphia, USA;  Drug Discovery and Therapy Congress May 11-14, 2016, Boston, USA; American Cardiology Congress 2016; 7th International Conference on Drug Discovery and Therapy, February 15-18, 2016 Dubai, UAE; 13th European Cardiology Congress October 17-19,2016 Rome,  Italy; Arrhythmias & the Heart: A Cardiovascular Update, February 12–16, 2016, Riyadh, Saudi Arabia; 16th Annual International Symposium on Congenital Heart Disease, February 13–16, 2016, St. Petersburg, ACC Annual Meeting 2016; USA; Cardiovascular Conference at Snowbird, February 12-15, 2016, Snowbird, Utah; American Cardiology Congress 2016 ; Korean Cardiology Related Societies Joint Scientific Congress, April 15-16, 2016, Daegu, Korea.

 

 

 

 

 

Conference Series LLC invites all the participants from all over the world to attend “10th International Conference on Molecular and Cellular Cardiology” during November 28-29, 2016 at Sao Paulo, Brazil organized by Conference Series LLC will bring together world-class professors, scientists and cardiologists to discuss strategies for disease remediation for heart in this cardiology conference. International cardiology conference 2016 is designed to provide diverse and current education that will keep medical professionals abreast of the issues affecting the prevention, diagnosis and treatment of cardiovascular disease which include prompt Keynote presentations, Postal presentations, Oral talks and Exhibitions.

The Molecular and Cellular Cardiology 2016 will be organized around the theme “Progress in Therapies for heart diseases ". 

Molecular and Cellular Cardiology is a conference to study the molecular mechanisms that underlie cardiovascular biology and disease. Molecular Cardiology also focuses on the role of lipid metabolism in the regulation of cell signalling in the heart and vasculature and investigates genetic and biological mechanisms of Heart and Cardiovascular disease. The major goals of Department of Molecular cardiology are 1) to continue Cleveland clinic’s long-lasting tradition of research in the area of cardiovascular biology, 2) to develop cutting edge research programs to address significant physiological and pathophysiological  mechanisms that occur in the heart and vasculature, 3) to maintain an active linkage between basic and clinical investigators with research programs in cardiovascular biology and 4) to provide educational opportunities for student and fellows to receive research training in cardiovascular biology. Our mission is to improve the treatments available for patients suffering from cardiovascular disease by combining basic research aimed at understanding the molecular mechanisms of heart disease with the discovery of innovative small molecule and cell-based therapeutics.

Conference Series LLC Organizes 300+ conferences, 500+ workshops such as electrocardiography workshops, cardiology diagnosis workshops, cardio myopathy workshops cardiology exhibitions and 200+ symposiums on Clinical, Medicine, Pharma and Science & Technology.

Conference Series LLC is glad to invite you to the 10th International Conference on Molecular and Cellular Cardiology November 28-29, 2016 Sao Paulo, Brazil.

Theme: Progress in Therapies for heart diseases

Molecular and Cellular Cardiology is a conference to study the molecular mechanisms that underlie cardiovascular biology and disease. Molecular Cardiology also focuses on the role of lipid metabolism in the regulation of cell signalling in the heart and vasculature and investigates genetic and biological mechanisms of Heart and Cardiovascular disease. Our mission is to improve the treatments available for patients suffering from cardiovascular disease by combining basic research aimed at understanding the molecular mechanisms of heart disease with the discovery of innovative small molecule and cell-based therapeutics.

Cardiac Conference aims to improve our understanding of the development of cardiovascular diseases with strong emphasis on diagnosis. Cardiac conference is to initiate a sustainable platform for exchanging up-to the minute upstream and downstream achievements, industrial needs and research opportunities of heart diseases fields, it provides a great opportunity to share in what has happened, be part of what is happening and influence the future direction in one of the fastest growing research sectors.

According to market analysis, heart disease is the number one cause of death in the world and the leading cause of death in the United States. Over the past 10 years for which statistics are available, the death rate from heart disease has fallen about 39% but the burden and risk factors remain alarmingly high. Cardiovascular diseases would be the largest cause of death and disability in by 2020 as per a World Health Organization (WHO) report.

Importance and Scope

A prospective survey of patients in 20th century electrocardiography, preventive cardiology and the Framingham Study, lipid hypotheses and atherosclerosis, coronary care units echocardiography, thrombolytic therapy, cardiac catheterization and coronary angiography, open-heart surgery, automatic implantable cardiac defibrillators, and coronary angioplasty. In Cardiology different changes made in the understanding of basic cardiovascular science and in the development of new diagnostic and therapeutic techniques.

Why Sao Paulo, Brazil?

Brazil currently faces a major health challenge: the pandemic scenario of cardiovascular morbidity and mortality. According to Brazilian Health Ministry data, 326,000 deaths due to cardiovascular diseases (CVD) occurred in 2010, corresponding to approximately 1,000 deaths/day, 200,000 deaths due exclusively to ischemic heart and cerebrovascular diseases, reflecting a gloomy scenario far from the minimally acceptable control .Cardiovascular death rates in Brazil 11.38% due to stroke, 5.37% to Atherosclerosis, 12.85  Hypertension

                           

                                                           Figure 1: Statistics of Cardiovascular Disease

 

Conference Highlights

  • Molecular Cardilogy
  • Cellular Cardiology
  • Nuclear cardiology
  • Cardiogenic Pulmonary Edema
  • Cardiac Cirrhosis
  • Genetic and Epigenetic Specifications
  • Regulation of Cardiac Function
  • Cardiac Hypertrophy
  • Cardiovascular Aging
  • Cardiac Progenitors
  • Ca++ and Na+ Dynamics
  • Recent innovations in Molecular Cardiology
  • Case Reports on Cardiac
  • Entrepreneurs Investment Meet

Why to attend?

With members from around the world focused on learning about Cardiology, this is your single best opportunity to reach the largest assemblage of participants from the hospitals, Universities, community, etc., Conduct demonstrations, distribute information, meet with current and potential researchers and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, tactics, and the newest updates in Cardiology field are hallmarks of this conference.

 

A Unique Opportunity for Advertisers and Sponsors at this International event:

http://annualmeeting.conferenceseries.com/cardiologists/sponsors.php

Societies Associated with Cardiac Research

Sao Paulo Statistics

  • International Cardiovascular Reference Center
  • The Sao Paulo State Society of Cardiology
  • Pediatric Cardiac Surgery Heart Institute University Society of Cardiovascular Anaesthesiologists
  • Sao Paulo State Society of Cardiovascular Surgery

Brazil Statistics

  • Brazilian Society of Cardiology
  • Cardiology Society Congress
  • Brazilian Congress of Cardiology
  • Center for Experimental Medicine
  • Brazilian Society of Cardiovascular Surgery
  • Catholic University of Brasilia

Global Statistics

  • American Society of Nuclear Cardiology
  • American College of Cardiology
  • Australia Heart Foundation
  • British Cardiac Society
  • International Society For Adult Congenital Cardiac Disease
  • Houston Methodist Debakey Cardiology Associates

Universities Associated with Cardiology Research

City Statistics

  • Heart Institute University of Sao Paulo
  • University of Sao Paulo

Country Statistics

  • University of Brazil
  • Duke Clinical Research Institute
  • University of Milano
  • Thrombosis Research Institute

Worldwide Statistics

  • Stanford  School of Medicine
  • University of Melbourne
  • University of Oxford
  • Imperial college of London
  • University of California, Los Angeles
  • Yale University
  • University of Cambridge
  • Harvard University

                               Figure 2: Statistics of Cardiology Universities

 

Industries Associated with Cardiology Research

City Statistics

  • Bayer Health Care Pharmaceuticals
  • EMS Pharmaceuticals

Country Statistics

  • EMS
  • Medley
  • Hypermarcas
  • Novartis
  • Roche
  • Pfizer
  • Ache

Worldwide Statistics

  • Novartis
  • Abbott Laboratories
  • Johnson & Johnson
  • Merck
  • Wyeth
  • Eli Lilly & Co
  • Amgen
  • Bristol-Meyers Squibb
  • Boston Scientific
  • Pfizer
  • Schering-Plough

Hospitals Associated with Cardiology Research

City Statistics

  • Hospital Samaritano
  • Cardiology Hospital do Coração
  • Funding Source Unic ́or Hospital

Country Statistics

  • Unified Health System Hospital
  • Tertiary Hospital in São José do Rio Preto Labatt Family Heart Centre
  • Sahloul University Hospital
  • Mazankowski Alberta  Heart Institute
  • Peter Munk Cardiac Centre

Worldwide Statistics

  • Fortis Hospital, Bangalore
  • Gleneagles Hospital, Singapore
  • Shouldice Hospital
  • Wooridul Spine Hospital
  • Bumrungad International Hospital
  • Barcelona Centre Medic
  • Bangkok Hospital Medical Center
  • Anadolu Medical Center
  •  Hospitals of the University of Pennsylvania-Penn Presbyterian, Philadelphia
  • Cedars-Sinai Medical Centre, Los Angeles, CA
  • St Francis Hospital, Roslyn, New York, NY
  • Mount Sinai Hospital, New York, NY

         

                                    Figure 3: Stastistics of Hospitals


Market Value on Cardiology Research

Cardiovascular disease is much more prevalent among patients over 55 years of age; therefore as the U.S. population ages, the incidence of cardiovascular disease will increase. In addition, rising rates of obesity will also contribute to the incidence of heart disease. As the baby boomer generation in the U.S. ages, the patient population will increase. This increase in the patient population will lead to an annual 3% to 4% increase in the number of patients requiring some type of arrhythmia treatment. Increasing prevalence of cardiovascular diseases coupled with adoption of minimally invasive surgeries is expected to boost the interventional cardiology device market over the forecast period. Unhealthy lifestyle habits such as high alcohol consumption, smoking, and lack of physical exercise are triggering incidences of cardiovascular diseases. Furthermore, the number of congenital heart disease patients is on a constant rise and this acts as a growth driver for the market.

                                                                                 

                                                              Figure 4: Stastics of Market Value                                                                                      

The global interventional cardiology and peripheral vascular devices market is 8.73 Billion with drug-eluting stents comprising the largest segment of the market, followed by coronary vascular closure devices, PTCA and cutting balloon catheters, bare-metal stents, intravascular ultrasound (IVUS) catheters, coronary introducer sheaths, interventional coronary guide wires, coronary embolic protection devices, interventional coronary catheters and balloon-inflation syringes.  Congenital heart defects are the most common birth defects affecting approximately 1% of the births every year.

The treatment of cardiovascular disorders has changed dramatically due to the introduction of new drug therapies and devices such as guide wires and stents allowing the patient to live better quality and longer lives. The fastest growing areas of the cardiac surgery market will be that of transcatheter heart valve devices. These devices are used for repairing and replacing heart valves without the need for open surgery. Cardiovascular industry growth continues to increase with the presence of multiple technologies such as advanced material and software which is featured in most of the devices. International companies tends to innovate, develop new products and to enhance the existing features in cardiovascular devices.

Products Manufactured by the Industry related Cardiology Research and its market value:

  • HeartWare –Heart Failure monitoring devices
  • CardioCommand, Inc. –ECG Monitoring Devices
  • Abbott Vascular Inc. -cardiac and vascular care devices
  • Atrium Medical Corporation -balloon expandable covered stents, local drug delivery, soft tissue and hernia repair, chest drainage devices, and vascular graft technologies.
  • Medivators –Cardiac Surgery Devices
  • SorinS.p.A.- artificial cardiac valves (mechanical and tissue valves), annuloplasty rings.
  • Miami Cardiovascular Innovations –Cardiovascular Therapeutics & Devices
  • Johnson & Johnson -personal care products in the beauty, skin care, nutritional, oral care, baby care.
  • Abbott Laboratories- specialized medicines; medical diagnostic instruments.
  • Boston Scientific -Ballons Dilatation and Expansion, interventional Cardiology devices
Cardiology-2015

 

In the presence of inter professional researchers and practitioners involved in the development of high quality education in all aspects of clinical skills, OMICS 5th International Conference on Clinical & Experimental Cardiology was held during April 27-29, 2015 in Philadelphia, USA

OMICS Group played host to a diverse panel of key members of the Cardiology community from research lab, industry, academia and financial investment practices, discussing the future of Cardiology specialties. This event was really aimed for examining where the real cardiological specialties are going in the future and purpose of the event was to provide an opportunity for cross fertilization of ideas and development of ideas, in the field of Cardiology.

Focusing on Heart Diseases, Congenital Heart Diseases, Cardiac Therapeutic Agents, Biophysics and Systems Biology, Interventional Cardiology, Cancer and Heart, Current Research in Cardiology and Cardiac Surgery as well, the three days of discussions enabled professionals to gain an insight into the current innovations and opened up networking opportunities.

Cardiology-2015 Organizing Committee would like to thank the Moderators of the conference, Dr. Anastasia Susie Mihailidou, Royal North Shore Hospital & Kolling Institute, Australia and Dr. Mahazarin Ginwalla, University Hospitals Case Medical Center, USA who contributed a lot for the smooth functioning of this event.

We are also thank full to all the speakers who made this event a grand success, our special thanks to Stacy Masucci, Elsevier and Dr. John E. Strobeck, Daxor Corporation  for exhibiting at the conference, many thanks to all the media partners for the promotion of our event.

The highlights of the meeting were the eponymous lectures, delivered by Louis Samuels from Thomas Jefferson University School of Medicine, The Lankenau Heart Institute, USA, Anthony Martin Gerdes from New York Institute of Technology-College of Osteopathic Medicine, USA, Kate M Denton from Monash University, Australia, Yoshiaki Omura from New York Medical College, Heart Disease Research Foundation, USA, Robert M Mentzer from Wayne State University School of Medicine, USA, Karlheinz Seidl from Klinikum Ingolstadt GmbH, Germany. These talks were of great interest to the general cardiologists and were enormously informative.

OMICS 5th International Conference on Clinical & Experimental Cardiology was a great success with the support of international, multiprofessional steering committee and coordinated by the Journal of Clinical & Experimental Cardiology, Journal of Cardiovascular Diseases & Diagnosis and Cardiovascular Pharmacology: Open Access.


Past Reports  Proceedings  Gallery  

Cardiology-2014

In the presence of inter professional researchers and practitioners involved in the development of high quality education in all aspects of clinical skills, OMICS 4th International Conference on Clinical & Experimental Cardiology was held during April 14-16, 2014 in San Antonio, USA

OMICS Group played host to a diverse panel of key members of the Cardiology community from research lab, industry, academia and financial investment practices, discussing the future of Cardiology specialties. This event was really aimed for examining where the real cardio logical specialties are going in the future and purpose of the event was to provide an opportunity for cross fertilization of ideas and development of ideas, in the field of Cardiology.

Focusing on Heart Diseases, Congenital Heart Diseases, Cardiac Therapeutic Agents, Biophysics and Systems Biology, Interventional Cardiology, Cancer and Heart, Current Research in Cardiology, and Cardiac Surgery as well, the three days of discussions enabled professionals to gain an insight into the current innovations and opened up networking opportunities.

Cardiology-2014 Organizing Committee would like to thank the Moderator of the conference, Dr. Anastasia Susie Mihailidou, Royal North Shore Hospital, Australia who contributed a lot for the smooth functioning of this event.

The highlights of the meeting were the eponymous lectures, delivered by Louis Samuels, Thomas Jefferson University School of Medicine, USA, Richard J. Frink, Heart Research Foundation of Sacramento, USA, Bradley Field Bale, Bale/Doneen Method, USA, Karlheinz Seidl, Klinikum Ingolstadt, Germany. These talks were of great interest to the general cardiologists and were enormously informative.

OMICS 4th International Conference on Clinical & Experimental Cardiology was a great success with the support of international, multiprofessional steering committee and coordinated by the Journal of Clinical & Experimental Cardiology, Journal of Cardiovascular Diseases & Diagnosis.


Past Reports  Gallery  

Cardiology-2013

3rd International Conference on Clinical & Experimental Cardiology (Cardiology -2013) held during April 15-17, 2013 at Chicago/Northbrook, USA, was a dynamic forum for all cardiologists, healthcare professionals, scientists and medical executives from around the world who are actively involved in patient care, research, therapeutics development including basic, translational, and clinical aspects, epidemiology, prevention, diagnosis, and drug discovery and development. The conference provided participants a platform to exchange ideas, and to share breakthroughs and promising solutions to the most important issues in the field.

The day featured formal presentations from key researchers as well as time for questions and informal discussion. The theme of the conference was “Emerging interventions in clinical cardiology and cardiac surgery”.

Keynote sessions were delivered by great speakers, Louis E Samuels, Lankenau Medical Center, USA, Vincent DOR, Centre Cardiothoracique de Monaco, Monaco Cedex, Richard J Frink, Heart Research Foundation of Sacramento, USA, Ming K Heng, University of California, USA. They made excellent presentations and their experiences gained inside/outside the lab were warmly discussed with the audiences at the keynote forum.

The conference was chaired by Xiaoping Ren, James D Fett, Ming k heng, Emad Aziz, Samuel C. Dudley, Anthony Ashton, Alexander D. Verin, Anastasia Susie Mihailidou, JanGlatz, Mentzer, Dr. Ramin Artang, Louis Samuels, and Geetha Bhat.

During the conference, a workshop was introduced by Jozsef Pal Vas and Noemi Csaszar, Hungarian Association of Hypnosis, Hungary. The title for the workshop was “Tandem hypnotherapy (THT) as a new method functioned at sensori-motor level”.
Along with the participants of Cardiology Conference, we would like to express our gratitude to Mr. Frank King, The Cardiac Comedian, for his special appearance at the conference.


Past Reports  Gallery  

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date November 28-29, 2016
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity
Poster Opportunity Available

Media Partners

Conferenceseries Destinations